microbial diseases laboratory

Publications by Year

2011 MDL Publications

Abbott SL. Chapter 37. Klebsiella, Enterobacter, Citrobacter, Serratia, Plesiomonas, and Other Enterobacteriaceae. In: Manual of Clinical Microbiology 10th edition May 2011, ASM Press.
Abbott SL, Janda JM, Farmer III JJ. Chapter 39. Vibrio and Related Organisms. In: Manual of Clinical Microbiology 10th edition May 2011, ASM Press.
Abbott SL, Moler S, Green N, Tran RK, Wainwright K, Janda JM. Clinical and Laboratory Diagnostic Characteristics and Cytotoxigenic Potential of Hafnia alvei and Hafnia paralvei Strains. J Clin Microbiol 2011 49(9):3122-3126.
Frink S, Qian L, Yu S, Cruz L, Desmond E, Douglas JT. Rapid deletion-based subtyping system for the Manila family of Mycobacterium tuberculosis. J Clin Microbiol 2011 May;49(5):1951-5.
Janda JM, Abbott SL. Revisiting Bacterial Gastroenteritis, Part I: Issues, Possible Approaches, and an Ever-Expanding List of Etiologic Agents. Clin Microbiol Newsletter 2011 33:71-76.
Kato-Maeda M, Gagneux S, Flores L, Kim E, Small P, Desmond E, Hopewell P. Strain classification of Mycobacterium tuberculosis: congruence between large sequence polymorphisms and spoligotypes. Int J Tuberc Lung Dis 2011 15(1):131-33.
Woods GL, Lin SY, Desmond EP. Chapter 73. Susceptibility Test Methods: Mycobacteria, Nocardia, and Other Actinomycetes. In: Manual of Clinical Microbiology 10th edition May 2011, ASM Press.
Yaeger J, Hudecek P, Fritz C, Gilliss D, Vugia DJ, Inami G, Brenden RA, Adams JK, Bopp CA, Trees E, Hill V, Kahler A, Pringle AJ, Williams I, Barton Behravesh C, Bennett SD, Mettee SL. Notes from the Field: Update on Human Salmonella typhimurium Infections Associated with Aquatic Frogs --- United States, 2009—2011. MMWR Weekly, May 20, 2011.
Yuan J,Inami G, Mohle-Boetani J, Vugia DJ. Recurrent Wound Botulism Among Injection Drug Users in California. Clin Infect Dis 2011 52(7):862–866.

2012 MDL Publications

Abbott SL, Ni FCY, Janda JM. Increase in Extraintestinal Infections Caused by Salmonella enterica Subspecies II–IV. Emerg Infect Dis 2012 Apr;18(4):637-639.
Bamrah S, Desmond E, Ghosh S, France AM, Kammerer JS, Cowan LS, Heetderks A, Forbes A, Moonan PK. Molecular Epidemiology of Mycobacterium tuberculosis in the United States-Affiliated Pacific Islands. Asia Pac J Public Health 2012 Dec 13. [Epub ahead of print]
Cowan LS, Hooks DP, Christianson S, Sharma MK, Alexander DC, Guthrie JL, Jamieson FB, Supply P, Allix-Béguec C, Cruz L, Desmond E, Kramer R, Lugo S, Rudrik J. Evaluation of mycobacterial interspersed repetitive-unit-variable-number tandem-repeat genotyping as performed in laboratories in Canada, France, and the United States. J Clin Microbiol 2012 May;50(5):1830-1.

2013 MDL Publications

Daley CL, Reves RR, Beard MA, Boyle J, Clark RB, Beebe JL, Catanzaro A, Chen L, Desmond E, Dorman SE, Hudson TW, Lardizabal AA, Kapoor H, Marder DC, Miranda C, Narita M, Reichman L, Schwab D, Seaworth BJ, Terpeluk P, Thanassi W, Kawamura LM. A summary of meeting proceedings on addressing variability around the cut point in serial interferon-γ release assay testing. Infect Control Hosp Epidemiol. 2013 Jun;34(6):625-30.
Horne DJ, Pinto LM, Arentz M, Lin SY, Desmond E, Flores LL, Steingart KR, Minion J. Diagnostic accuracy and reproducibility of WHO-endorsed phenotypic drug susceptibility testing methods for first-line and second-line antituberculosis drugs. J Clin Microbiol. 2013 Feb;51(2):393-401.

2014 MDL Publications

Desmond, E., and Peter, C. 2014. International Tuberculosis Laboratory Consulting. Clinical Microbiology Newsletter 36 (16): 123 - 128
Berrada, Z.L., Lin S-Y G, Nguyen D, Schecter GF, Janda JM, Elmaraachli W, Rodwell TR, Catanzaro A, and Desmond E. 2014. Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex. J. Clin. Microbiol. Manuscript submitted.
Ajbani, K., Lin S-Y G, Rodrigues C, Nguyen D, Arroyo F, Kaping J, Jackson L, Garfein RS, Catanzaro D, Eisenach K, Victor TC, Crudu V, Gler MT, Ismail N, Desmond E, Catanzaro A, and Rodwell TC. 2014. Evaluation of pyrosequencing for detecting extensively drug-resistant tuberculosis (XDR-TB) in clinical isolates from four highburden countries. Antimicrob. Agents Chemother. In press.
Lin, S.Y., and Desmond E.P. 2014. Molecular Diagnosis of Tuberculosis and Drug Resistance Clin Lab Med. 34(2):297-314.
England, K. and E. Desmond. 2014. Building bridges with North Korea: engaging through health diplomacy. Cultures 1(2):26-33.
Trollip, A. P.; Moore, D. Coronel, J.; Caviedes, L. Klages, S.; Victor, T.; Romancenco, E. Crudu, V. Ajbani, K.; Vineet, V. P.; Rodrigues, C.; Jackson, R. L. Eisenach, K.; Garfein, R. S.; Rodwell, T. C.; Desmond, E.; Groessl, E. J.; Ganiats, T. G.; Catanzaro, A. 2014. Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay. Int J. Tuberc Lung Dis. 18(2):227-32
Rodwell, T., F. Valafar, J. Douglas, L. Qian, R. Garfein, A. Chawla, J. Torres, V. Zadorozhny, M-S Kim, M. Hoshide, D. Catanzaro, L. Jackson, S.-Y. G. Lin, E. Desmond, C. Rodrigues, K. Eisenach, T. Victor, V. Crudu, N. Ismail, M.T. Gler, and A. Catanzaro. 2014. Predicting Extensively Drug-resistant Tuberculosis (XDR-TB Phenotypes with Genetic Mutations. J. Clin. Microbiol. 52(3): 781-9.
Lin, S-Y. Grace, T. Rodwell, T. Victor, L. Jackson, L. Pham, E. Rider, A. Catanzaro, and E. Desmond. 2014. Pyrosequencing for Rapid Detection of Extensively Drug-Resistant Tuberculosis in Clinical Isolates and Clinical Specimens. J. Clin. Microbiol. 52(2):475-82.

2015 MDL Publications

Greninger AL, Kozyreva V, Truong L, Graves M, Chaturvedi V. (2015). Draft genome sequence of Turicella otitidis TD1, isolated from a patient with bacteremia. Genome Announcements (In press).
Greninger AL, Kozyreva V, Truong L, Longoria R, Chaturvedi V. (2015). Draft genome sequence of Kerstersia gyiorum CG1 isolated from leg ulcer. Genome Announcements (In press).
Greninger AL, Chorny I, Knowles S, Ng VL, Chaturvedi V. (2015). Draft Genome Sequences of the four NDM-1-producing Klebsiella pneumoniae strains from a healthcare facility in Northern California. Genome Announcements. e00421-15
Inderlied, C., and E. Desmond. 2015. Antimycobacterial Agents: InVitro Susceptibility Testing and Mechanisms of Action and Resistance. In: Antibiotics in Laboratory Medicine, 6th ed., Wolters Kluwer, Philadelphia. Pp 161-249
Peter, C., Desmond, E., Murtaugh W., Rider, E., Ferguson, R., Liska, S., Warshauer, D., Berrada, Z., Zallocco, D. Gilpin, C., H.Albert, K. England, H. Alexander, A. Piatek, and A. Korobitsyn. 2015. Guide for providing technical support to TB laboratories in low and middle-income countries. World Health Organization, Global Laboratory Initiative, Geneva, Switzerland.
Woods, G.L., S-Y Lin, and E. Desmond. 2015. Susceptibility test methods: mycobacteria, Nocardia, and other actinomycetes. In: Manual of Clinical Microbiology, 11th ed., Amer. Soc. Microbiol., Washington, D.C., Chapter 76
El Maraachli, W., M. Slater, Z.L. Berrada, S-Y. G. Lin, A. Catanzaro, E. Desmond, C. Rodrigues, T.C. Victor, V. Crudu, M.T. Gler, and T.C. Rodwell. 2015. Predicting differential rifamycins resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations. Int. J. Tuberc Lung Dis. 19 (10): in press.
Catanzaro, A; Rodwell, TC; Catanzaro, DG; Garfein, RS; Jackson, RL; Seifert, M; Georghiou, SB; Trollip, A; Groessl, E; Hillery, N; Crudu, V; Victor, TC; Rodrigues, C; Lin, SY; Valafar, F; Desmond, E; and Eisenach, K. 2015. Performance comparison of three rapid tests for diagnosis of drug-resistant tuberculosis. Manuscript submitted.
Tans-Kersten, J. S-Y.G. Lin, MS, E. Desmond, PhD., and D. Warshauer. 2015. Evaluation of shared laboratory services: detection of M. tuberculosis complex and drug resistance using molecular and culture-based methods. Public Health Reports: In Press.